Encision Inc.
Moat Score — Encision Inc.
Total Moat Score
7 / 30
| Moat Factor | Score | Analysis |
|---|---|---|
| Intangible Assets Patents, trademarks, brand strength, or regulatory licenses that protect a company's products or services from being freely copied by competitors. | 3 / 5 | Encision holds 21 unexpired U.S. patents plus international patents (Europe, Japan, Canada, Australia) and FDA 510(k) clearance for its AEM safety technology — a genuine, protected clinical differentiator versus conventional monopolar instruments. |
| Cost Advantage A durable ability to produce goods or services more cheaply than competitors — through scale, unique access to cheap inputs, location, or process — that lets a company undercut rivals or out-earn them at the same price. | 0 / 5 | With only 24 employees and $6.2 million in annual product revenue, Encision has no manufacturing or purchasing scale advantage versus the Medtronic and Johnson & Johnson divisions it competes against. |
| Pricing Power The ability to raise prices without losing meaningful business, because the product or service is differentiated, mission-critical, or has few good substitutes. | 1 / 5 | As a micro-cap competing against vastly larger medical device divisions, Encision has limited ability to command premium pricing despite its safety differentiation, reflected in persistently thin revenue and narrow margins. |
| Network Effect The product or service becomes more valuable to every user as more people or organizations use it, making an established leader harder to displace. | 0 / 5 | Surgical safety devices carry no network effect; adoption is driven by individual hospital procurement and physician training, not by the number of other hospitals using the product. |
| Switching Costs The money, time, or operational disruption a customer would face switching to a competitor, which locks in existing customers and supports renewals. | 2 / 5 | Established relationships including VA medical system contracts and a Vizient Innovative Technology Contract create some institutional stickiness, and hospital staff training on AEM-specific equipment adds modest switching friction once adopted. |
| Efficient Scale A market that can only profitably support a small number of players, so incumbents face limited threat from new entrants even without other defenses. | 1 / 5 | The addressable market (~4.4 million U.S. laparoscopic procedures annually, ~$500 million monopolar instrument market) is not inherently scale-limited in a way that protects Encision from larger entrants; its competitors are simply much larger incumbents in the same open market. |